Ir Celldex. The Investor Relations website contains information about Celldex Therapeutics's business for stockholders, potential investors...
Ir Celldex. The Investor Relations website contains information about Celldex Therapeutics's business for stockholders, potential investors...
What’s new on Ir.celldex.com: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Ir.celldex.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.
HAMPTON, N.J., Feb. 20, 2016 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today presented new clinical data on CDX-301 (recombinant human Flt3 ligand), a potent hematopoietic cytokine that uniquely expands dendritic cells and hematopoietic...
--Clinical benefit observed across multiple endpoints, including PFS, OS, ORR and steroid requirement-- --All subgroup analyses favor RINTEGA treatment--HAMPTON, N.J., May 31, 2015 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) today presented...
Biotech stocks sailed into 2014 backed by a favorable wind, but springtime has stymied the sector in confused seas. Companies on The Life Sciences Report’s 2014 Biotech Watchlist have hit the doldrums along with the rest, as faithful...
Antibody Drug Conjugate Market Antibody drug conjugates (ADCs), also known as anti-cancer drugs are promising and effective modalities for cancer therapies. The Antibody drug conjugates ADCs are prepared by combining two principles i.e. monoclonal antibody...
About Therapeutic Vaccines A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual with...
Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.
Welcome to Digestive Medical Solutions, your premiere integrative gastrointestinal healthcare providers. We offer a results-driven...
Managing Myeloma is an educational initiative dedicated to developing tools, information, and resources that support improved ther...
Investor Relations | Celldex Therapeutics
The Investor Relations website contains information about Celldex Therapeutics's business for stockholders, potential investors, and financial analysts.
Contact Us | Celldex Therapeutics
Shareholder Inquiries Communications concerning transfer requirements, lost certificates and changes of address should be directed to the Registrar and Transfer Agent. Investor and Media Inquiries Ana...
Dec 8, 2012 Final Data from Celldex Therapeutic's CDX-011 Phase 2 Study in Metastatic Breast Cancer Supports Overall Survival Benefit in Patients with High GPNMB Expression --Broad activity with great...
20 years
Domain age
N/A
Visit duration
N/A
Daily visitors
N/A
Bounce rate
82.7 %
USA